Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1433-2965

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis ; day:10 ; month:10 ; year:2018 ; pages:1-9
Osteoporosis international ; (10.10.2018), 1-9

Creator: Torres, L.

Contributor: Klingberg, E.
Nurkkala, M.
Carlsten, H.
Forsblad-d’Elia, H.
SpringerLink (Online service)

DOI: 10.1007/s00198-018-4721-4

URN: urn:nbn:de:101:1-2018111822022350078722

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Torres, L.
Klingberg, E.
Nurkkala, M.
Carlsten, H.
Forsblad-d’Elia, H.
SpringerLink (Online service)

Other Objects (12)

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Osteoporosis in ankylosing spondylitis - prevalence, risk factors and methods of assessment

Andersson lesion in ankylosing spondylitis

Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker

Surgical treatment of ankylosing spondylitis deformity

Secukinumab: A Review in Ankylosing Spondylitis

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?

Is there a relation between pre-sarcopenia, sarcopenia, cachexia and osteoporosis in patients with ankylosing spondylitis?

ANKHvariants associated with ankylosing spondylitis: gender differences

Association between ankylosing spondylitis and m6A methylation

Atherosclerosis in Egyptian patients with ankylosing spondylitis

Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis

Related objects

Reset password